While Progyny Inc has overperformed by 2.15%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, PGNY fell by -39.70%, with highs and lows ranging from $38.98 to $13.39, whereas the simple moving average jumped by 7.35% in the last 200 days.
On December 02, 2024, JP Morgan Downgraded Progyny Inc (NASDAQ: PGNY) to Neutral. A report published by Truist on November 13, 2024, Downgraded its rating to ‘Hold’ for PGNY. Leerink Partners August 07, 2024d the rating to Market Perform on August 07, 2024, and set its price target from $31 to $25. Canaccord Genuity August 07, 2024d its ‘Buy’ rating to ‘Hold’ for PGNY, as published in its report on August 07, 2024. JMP Securities also rated the stock as ‘Mkt Outperform’.
Analysis of Progyny Inc (PGNY)
Further, the quarter-over-quarter increase in sales is 10.55%, showing a positive trend in the upcoming months.
In order to gain a clear picture of Progyny Inc’s future performance, a variety of well-rounded analysis and research techniques can be applied, with equity being the most critical. The goal here is to ensure that your current return on equity of 11.14% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 2.80, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
An average volume of 1.95M can be a very valuable indicator of volatility for PGNY stock. On a monthly basis, the volatility of the stock is set at 4.47%, whereas on a weekly basis, it is put at 2.84%, with a gain of 2.91% over the past seven days. Furthermore, long-term investors anticipate a median target price of $26.57, showing growth from the present price of $22.31, which can serve as yet another indication of whether PGNY is worth investing in or should be passed over.
How Do You Analyze Progyny Inc Shares?
The USA based company Progyny Inc (PGNY) is one of the biggest names in Healthcare Plans. When comparing Progyny Inc shares with other companies under Healthcare, the P/E value is an influential factor to note. This is because it represents an indication of the future growth of the company in terms of investors’ expectations. Ultimately, the value of the latter should demonstrate steady, rapid growth, which is an accurate measure of the company’s progress. In addition to the value of 39.47, there is a growth in quarterly earnings of -11.44%.
In addition to the fundamentals, you should also consider how many employees own shares in the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 16.44%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 89.99% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
PGNY shares are owned by institutional investors to the tune of 89.99% at present.
